(go to content)

Castellano | Euskara | Français | English

 Imagen decorativa
DTB: Vol 23, No 1

Content tools

Share it

  • Meneame
  • Delicious
  • Twitter
  • Google
  • Facebook

Orphan drugs: regulation and controversies

Encouragement of research and development of drugs for rare diseases is merited, but should be directed to the most relevant ones. Given the difficulty involved, research on orphan drugs should be carried out under maximum quality standards. Research funding should be reviewed in order to make it sustainable and to ensure that equitable access to drugs is guaranteed. Keywords: orphan drugs, rare diseases

Download pdf     


  • Javier Garjón. Drug Prescribing Service. Navarre Health Service. Spain


 - Link to the video "Orphan Drugs"

Enviar comentario

You can send us a comment or suggestion and we will respond to most frequently asked questions

Competing interests (complete this field only if you have competing interests)






Government of Navarre

Contact us | Accessibility | Legal notice | Site map